Banner Thunderbird Medical Center

Banner Thunderbird Medical Center was paid $140.26M by Medicaid between Jan 2018 and Dec 2024, across 474 billing codes. Its largest line is 99285, emergency room visit (most serious) — 25% of everything it billed.

33Billing provider infoBANNER THUNDERBIRD MEDICAL CENTER
GLENDALE, AZ 85306

33aNPI1154355188assigned 07/10/2006

33bProvider typeInfusion Therapy Clinic/Center

28Total paid$140.26M

24GClaims3,378,165

24DCodes billed474

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Infusion Therapy Clinic/Center providers in Arizona

Rank by total paid#1 of 7

Median peer was paid$275K

This provider vs. median509×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	524,835	$22.89M
2019	475,927	$23.02M
2020	367,871	$18.14M
2021	492,425	$20.15M
2022	541,266	$20.22M
2023	543,190	$20.26M
2024incomplete	432,651	$15.58M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	25%	77,312	69,115	$35.28M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	20%	95,763	88,694	$28.00M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	75,768	71,794	$18.53M
74177	Computed tomography, abdomen and pelvis; with contrast material	8.4%	18,569	17,394	$11.72M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	4.1%	6,497	5,835	$5.69M
74176	Computed tomography, abdomen and pelvis; without contrast material	3.0%	9,942	9,181	$4.16M
47562		2.8%	1,101	1,039	$3.90M
70450	Computed tomography, head or brain; without contrast material	2.2%	24,168	21,985	$3.06M
44970		1.8%	736	703	$2.59M
G0378	Hospital observation service, per hour	1.8%	76,659	35,747	$2.54M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.6%	22,930	22,013	$2.30M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.1%	2,349	2,248	$1.60M

462 more codes

C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	1.1%	1,554	$1.49M
58571		<1%	316	$1.36M
72125	Computed tomography, cervical spine; without contrast material	<1%	7,744	$1.10M
70496		<1%	2,061	$948K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,882	$780K
99213	Doctor's office visit, returning patient (routine)	<1%	7,703	$752K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	4,099	$708K
93458		<1%	317	$707K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	7,897	$618K
71275	Computed tomographic angiography, chest, with contrast material	<1%	6,050	$545K
74174		<1%	710	$518K
93970		<1%	2,938	$488K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	32,469	$464K
80053	Comprehensive metabolic panel	<1%	160,891	$456K
36430		<1%	2,804	$411K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	524	$407K
99214	Doctor's office visit, returning patient (more involved)	<1%	2,441	$361K
58670		<1%	135	$344K
75574		<1%	915	$340K
70491		<1%	911	$329K
99203	Doctor's office visit, new patient (routine)	<1%	2,937	$327K
72131		<1%	879	$309K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,915	$300K
54161		<1%	266	$288K
49083		<1%	1,461	$282K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,665	$267K
72146		<1%	922	$240K
90378		<1%	475	$238K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	135	$232K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,468	$228K
95812		<1%	1,683	$228K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	34,637	$191K
71250		<1%	1,877	$186K
93798		<1%	3,050	$181K
59025	Fetal non-stress test	<1%	2,520	$180K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	37,270	$157K
93971		<1%	4,916	$156K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	1,739	$142K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	7,604	$139K
70486		<1%	2,603	$133K
70487		<1%	263	$127K
99215	Doctor's office visit, returning patient (complex)	<1%	949	$126K
L8699	Prosthetic implant, not otherwise specified	<1%	206	$118K
A9585	Injection, gadobutrol, 0.1 ml	<1%	2,166	$115K
80320		<1%	24,031	$114K
J1756	Injection, iron sucrose, 1 mg	<1%	2,828	$113K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	72,096	$104K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	67,126	$104K
77012		<1%	145	$101K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,777	$101K
88307		<1%	2,288	$98K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	10,353	$93K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	126	$82K
70498		<1%	2,069	$81K
92611		<1%	494	$68K
74455		<1%	260	$68K
95816		<1%	578	$60K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,601	$57K
C1769	Guide wire	<1%	3,593	$56K
96375	Therapeutic injection; each additional sequential IV push	<1%	67,901	$55K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	111	$54K
96376		<1%	34,174	$49K
C1776	Joint device (implantable)	<1%	74	$46K
99204	Doctor's office visit, new patient (more involved)	<1%	260	$45K
10060		<1%	691	$43K
12001		<1%	2,027	$41K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	1,378	$38K
12011		<1%	2,075	$35K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,287	$34K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	1,964	$34K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	74	$33K
86920		<1%	1,393	$32K
82728		<1%	3,159	$31K
76819	Fetal biophysical profile; without non-stress testing	<1%	1,263	$31K
96361	Intravenous infusion, hydration; each additional hour	<1%	21,257	$30K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	7,654	$27K
74230		<1%	499	$25K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	10,230	$25K
J2357	Injection, omalizumab, 5 mg	<1%	346	$25K
97113		<1%	367	$24K
72141		<1%	1,241	$24K
80048	Basic metabolic panel (calcium, ionized)	<1%	32,258	$24K
36561		<1%	14	$23K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	24,750	$23K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	3,170	$23K
93976		<1%	6,563	$23K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	172,166	$22K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	498	$21K
C1889	Implantable/insertable device, not otherwise classified	<1%	29	$21K
76770		<1%	703	$20K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	8,574	$19K
76775		<1%	2,251	$18K
86923		<1%	3,296	$17K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,600	$17K
12002		<1%	1,202	$16K
20680		<1%	14	$15K
71046	Radiologic examination, chest; 2 views	<1%	20,270	$14K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	404	$14K
11045		<1%	20	$14K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,269	$13K
95714		<1%	136	$13K
G0390	Trauma response team associated with hospital critical care service	<1%	14	$13K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	615	$12K
36591		<1%	4,257	$12K
C1781	Mesh (implantable)	<1%	336	$12K
96367		<1%	5,772	$12K
82657		<1%	183	$11K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	109	$11K
86850		<1%	12,182	$11K
0225U		<1%	298	$11K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	214	$11K
J0897	Injection, denosumab, 1 mg	<1%	28	$10K
11043		<1%	15	$9K
82947		<1%	63,727	$9K
71045	Radiologic examination, chest; single view	<1%	47,720	$8K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	482	$8K
97161		<1%	4,493	$8K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,407	$8K
97166		<1%	1,407	$6K
73630		<1%	3,892	$6K
97162		<1%	1,419	$6K
J3490	Unclassified drugs	<1%	103,176	$6K
87040		<1%	26,256	$6K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,135	$6K
97165		<1%	2,098	$6K
80329		<1%	3,114	$6K
87086	Culture, bacterial; quantitative colony count, urine	<1%	29,890	$6K
88341		<1%	83	$6K
29581		<1%	564	$5K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	13,292	$5K
76801		<1%	5,376	$5K
J8540	Dexamethasone, oral, 0.25 mg	<1%	2,945	$5K
74018		<1%	5,560	$5K
84702		<1%	21,658	$5K
97535	Self-care/home management training, each 15 minutes	<1%	5,757	$5K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	66,702	$5K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	75	$4K
82805		<1%	2,417	$4K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	13	$4K
84484		<1%	58,621	$4K
0450	Emergency room services	<1%	89	$4K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	6,338	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	6,385	$4K
73610		<1%	3,649	$4K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	18,323	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,311	$3K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,453	$3K
84443	Thyroid stimulating hormone (TSH)	<1%	13,492	$3K
87631		<1%	8,365	$3K
92526		<1%	101	$3K
99195		<1%	58	$3K
51600		<1%	260	$3K
96523		<1%	185	$3K
83690		<1%	44,244	$3K
88304		<1%	3,271	$3K
76830	Ultrasound, transvaginal	<1%	3,182	$3K
87075		<1%	1,280	$3K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	33,054	$3K
73562		<1%	5,309	$3K
73130		<1%	3,442	$2K
72100		<1%	3,064	$2K
81025		<1%	15,878	$2K
97163		<1%	15	$2K
94762		<1%	5,267	$2K
84703		<1%	27,479	$2K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,994	$2K
73080		<1%	1,706	$2K
95819		<1%	15	$2K
81001		<1%	52,314	$2K
73502		<1%	2,518	$2K
72128		<1%	54	$1K
73030		<1%	4,220	$1K
83880		<1%	12,179	$1K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,842	$1K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,379	$1K
93017		<1%	528	$1K
76870		<1%	1,127	$1K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,230	$1K
83735		<1%	32,499	$1K
92610		<1%	63	$1K
73110		<1%	2,378	$985.78
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,487	$963.50
C9113	Injection, pantoprazole sodium, per vial	<1%	9,636	$946.67
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	148,697	$911.09
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	34,976	$864.49
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	267	$864.10
83605		<1%	20,379	$779.52
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,106	$722.52
J2270	Injection, morphine sulfate, up to 10 mg	<1%	38,495	$718.04
85610		<1%	29,547	$716.57
85027		<1%	23,058	$701.88
93880		<1%	126	$696.90
73090		<1%	2,769	$678.69
85384		<1%	1,553	$661.71
73140		<1%	939	$652.98
G0379	Direct admission of patient for hospital observation care	<1%	2,069	$635.12
J7030	Infusion, normal saline solution , 1000 cc	<1%	39,182	$632.85
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,555	$595.74
J2704	Injection, propofol, 10 mg	<1%	17,431	$583.47
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	365	$577.06
94760		<1%	14,474	$557.91
85730		<1%	12,860	$556.83
90715		<1%	3,424	$468.19
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	7,111	$461.68
86635		<1%	759	$459.48
73620		<1%	520	$458.82
87186		<1%	7,165	$454.77
J1650	Injection, enoxaparin sodium, 10 mg	<1%	13,231	$444.93
80061	Lipid panel	<1%	3,153	$438.46
86900		<1%	14,643	$430.21
87210		<1%	6,929	$424.09
76882		<1%	269	$421.99
86901		<1%	14,831	$418.04
73590		<1%	2,695	$411.82
87088		<1%	17,135	$410.82
J8597	Antiemetic drug, oral, not otherwise specified	<1%	17,502	$410.07
72072		<1%	785	$408.96
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	29,862	$402.68
87070		<1%	3,400	$390.00
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	1,984	$372.60
74021		<1%	3,749	$366.75
82784		<1%	264	$361.63
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	6,225	$358.45
85379		<1%	3,176	$349.17
A9270	Non-covered item or service	<1%	163,961	$316.00
73600		<1%	315	$312.00
J7120	Ringers lactate infusion, up to 1000 cc	<1%	3,561	$301.04
73060		<1%	709	$299.17
81003		<1%	22,723	$297.46
76604		<1%	250	$292.91
73552		<1%	981	$291.15
84145		<1%	4,486	$280.61
84112		<1%	2,061	$279.88
85240		<1%	12	$270.64
87077		<1%	8,558	$258.22
74022		<1%	1,391	$247.84
J0780	Injection, prochlorperazine, up to 10 mg	<1%	4,332	$246.36
82731		<1%	187	$239.54
82550		<1%	10,892	$238.84
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	4,496	$236.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	21,745	$232.50
86140		<1%	11,899	$229.18
74420		<1%	84	$228.94
85460		<1%	748	$214.49
85055		<1%	4,861	$212.55
J2785	Injection, regadenoson, 0.1 mg	<1%	431	$212.47
97116		<1%	5,556	$198.36
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	14,020	$193.30
87081		<1%	4,149	$190.84
90732		<1%	57	$190.60
82565		<1%	4,129	$187.87
83036	Hemoglobin; glycosylated (A1C)	<1%	4,507	$181.45
J1953	Injection, levetiracetam, 10 mg	<1%	1,420	$166.96
73564		<1%	39	$161.12
88342		<1%	834	$151.77
C2617	Stent, non-coronary, temporary, without delivery system	<1%	68	$151.60
72170		<1%	1,478	$151.32
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	3,022	$141.41
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,808	$139.88
62270		<1%	33	$136.80
J2060	Injection, lorazepam, 2 mg	<1%	7,608	$127.98
70360		<1%	144	$126.52
73120		<1%	390	$121.82
82248		<1%	260	$113.00
C1758	Catheter, ureteral	<1%	141	$112.94
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,527	$112.55
84100		<1%	9,145	$111.68
72040		<1%	500	$108.13
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,833	$105.19
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	5,149	$104.79
86870		<1%	72	$102.50
96368		<1%	1,501	$101.02
J2550	Injection, promethazine hcl, up to 50 mg	<1%	5,248	$98.32
84132		<1%	9,112	$93.33
86308		<1%	890	$92.26
51702		<1%	292	$91.64
J3480	Injection, potassium chloride, per 2 meq	<1%	4,676	$88.36
82607		<1%	1,501	$79.06
84466		<1%	2,828	$78.08
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	660	$74.08
43235		<1%	16	$72.00
85046		<1%	2,622	$67.64
87449		<1%	957	$67.21
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	2,369	$53.77
83615		<1%	1,524	$51.59
J1940	Injection, furosemide, up to 20 mg	<1%	3,161	$48.57
85014		<1%	3,489	$48.47
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	2,655	$48.36
71101		<1%	304	$47.94
86769		<1%	491	$42.96
85652		<1%	4,483	$41.73
82140		<1%	2,151	$39.55
84439		<1%	2,535	$39.35
87205		<1%	3,986	$38.84
87340		<1%	505	$37.17
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	138	$36.60
73070		<1%	398	$36.31
87427		<1%	408	$35.28
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	6,084	$33.38
86592		<1%	615	$32.80
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,249	$32.77
J0456	Injection, azithromycin, 500 mg	<1%	2,219	$32.41
82010		<1%	2,655	$32.10
J1170	Injection, hydromorphone, up to 4 mg	<1%	6,555	$31.67
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	4,192	$31.49
J1815	Injection, insulin, per 5 units	<1%	17,541	$29.22
87045		<1%	549	$29.09
86803		<1%	132	$27.40
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	1,519	$26.41
J3535	Drug administered through a metered dose inhaler	<1%	778	$25.99
82270		<1%	497	$25.27
J1630	Injection, haloperidol, up to 5 mg	<1%	2,175	$24.09
99152		<1%	2,062	$23.32
84156		<1%	2,328	$23.07
94761		<1%	622	$22.83
84460		<1%	1,279	$22.44
82570		<1%	426	$19.63
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,558	$19.56
82378		<1%	180	$19.33
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	16,349	$18.57
J1644	Injection, heparin sodium, per 1000 units	<1%	10,087	$18.01
83540		<1%	2,874	$17.29
82553		<1%	594	$16.65
94664		<1%	447	$15.32
82746		<1%	490	$14.52
J3370	Injection, vancomycin hcl, 500 mg	<1%	5,796	$14.40
73560		<1%	409	$14.07
84550		<1%	2,365	$12.30
G0008	Administration of influenza virus vaccine	<1%	1,175	$11.86
96415		<1%	1,605	$11.53
87147		<1%	1,050	$9.98
80164		<1%	1,185	$9.78
87807		<1%	431	$8.57
90686		<1%	1,217	$7.73
96417		<1%	512	$7.67
87116		<1%	323	$7.23
84295		<1%	3,688	$7.07
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,830	$6.96
82435		<1%	2,092	$6.67
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	4,914	$6.48
84520		<1%	3,681	$6.38
J7999	Compounded drug, not otherwise classified	<1%	2,451	$5.90
87102		<1%	423	$5.89
85018		<1%	5,612	$5.84
84450		<1%	584	$5.06
J1790	Injection, droperidol, up to 5 mg	<1%	939	$4.21
82945		<1%	336	$4.05
J2469	Injection, palonosetron hcl, 25 mcg	<1%	215	$3.91
84157		<1%	382	$3.77
84300		<1%	71	$3.50
S0028	Injection, famotidine, 20 mg	<1%	1,478	$3.13
J1956	Injection, levofloxacin, 250 mg	<1%	3,376	$1.78
J7050	Infusion, normal saline solution, 250 cc	<1%	960	$1.24
89051		<1%	1,703	$0.96
82330		0%	1,474	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	635	$0.00
87276		0%	58	$0.00
95700		0%	187	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	156	$0.00
87206		0%	506	$0.00
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	0%	257	$0.00
J1836	Injection, metronidazole, 10 mg	0%	526	$0.00
86780		0%	80	$0.00
76377		0%	1,669	$0.00
80178		0%	285	$0.00
82533		0%	54	$0.00
99153	Mod sedat endo service >5yrs	0%	1,161	$0.00
C9399	Unclassified drugs or biologicals	0%	212	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	63	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	275	$0.00
87046		0%	257	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	177	$0.00
J0571	Buprenorphine, oral, 1 mg	0%	32	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	422	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	228	$0.00
36415	Collection of venous blood by venipuncture	0%	341	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	67	$0.00
97010		0%	177	$0.00
93320		0%	59	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	71	$0.00
87015		0%	73	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	61	$0.00
90632		0%	14	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	81	$0.00
77001		0%	45	$0.00
74019		0%	145	$0.00
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	0%	18	$0.00
G0009	Administration of pneumococcal vaccine	0%	44	$0.00
87280		0%	16	$0.00
87632		0%	42	$0.00
87184		0%	54	$0.00
83930		0%	43	$0.00
73660		0%	52	$0.00
83021		0%	13	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	86	$0.00
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	0%	16	$0.00
94644		0%	17	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	13	$0.00
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	0%	12	$0.00
J1453	Injection, fosaprepitant, 1 mg	0%	40	$0.00
J3105	Injection, terbutaline sulfate, up to 1 mg	0%	126	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	417	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	505	$0.00
87899		0%	366	$0.00
87324		0%	172	$0.00
73000		0%	94	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	543	$0.00
88112		0%	623	$0.00
J7510	Prednisolone oral, per 5 mg	0%	916	$0.00
82375		0%	854	$0.00
85007		0%	467	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	537	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	549	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	200	$0.00
93325		0%	595	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	237	$0.00
80074		0%	133	$0.00
0042T		0%	142	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	555	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	262	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	542	$0.00
76937		0%	172	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	103	$0.00
82365		0%	13	$0.00
J3371	Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg	0%	55	$0.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	0%	909	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	86	$0.00
87254		0%	152	$0.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	0%	78	$0.00
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	0%	76	$0.00
29125		0%	186	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	121	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	248	$0.00
80202		0%	234	$0.00
73100		0%	61	$0.00
C1788	Port, indwelling (implantable)	0%	26	$0.00
76857		0%	14	$0.00
Q0114	Fern test	0%	446	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	531	$0.00
93041		0%	55	$0.00
82247		0%	73	$0.00
J2310	Injection, naloxone hydrochloride, per 1 mg	0%	28	$0.00
76000		0%	29	$0.00
J0736	Injection, clindamycin phosphate, 300 mg	0%	85	$0.00
96401		0%	101	$0.00
J0694	Injection, cefoxitin sodium, 1 gm	0%	79	$0.00
86789		0%	14	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	17	$0.00
85347		0%	24	$0.00
93975		0%	12	$0.00
87275		0%	58	$0.00
J2800	Injection, methocarbamol, up to 10 ml	0%	12	$0.00
Q9961	High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml	0%	16	$0.00
85520		0%	39	$0.00
88313		0%	23	$0.00
94770		0%	13	$0.00
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	0%	29	$0.00
C1729	Catheter, drainage	0%	43	$0.00
29515		0%	12	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	19	$0.00
86788		0%	14	$0.00
C1874	Stent, coated/covered, with delivery system	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFLORRES, DEBBIE (CEO)

Parent organizationBANNER HEALTH